Surgical management of submucosal esophageal cancer: Extended or regional lymphadenectomy?

Annals of Surgery

Volumn 252, Issue 5, 2010, Pages 823-829

  Grotenhuis, Brechtje A ^a   Van Heijl, M ^b   Zehetner, J ^c   Moons, J ^d   Wijnhoven, B P L ^a   Van Berge Henegouwen, M I ^b   Tilanus, H W ^a   Demeester, T R ^c   Lerut, T ^d   Van Lanschot, J J B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BODY MASS; CONFERENCE PAPER; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL APPROACH; TRANSTHORACIC BIOPSY; TREATMENT OUTCOME; ANASTOMOSIS LEAKAGE; ARTIFICIAL VENTILATION; BELGIUM; CANCER PATIENT; CANCER SURGERY; CHYLE; CHYLURIA; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HEART INFARCTION; HISTOPATHOLOGY; LYMPH NODE; LYMPH NODE METASTASIS; MULTICENTER STUDY; NETHERLANDS; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; PROSPECTIVE STUDY; REOPERATION; RESPIRATORY FAILURE; SEPSIS; SUBMUCOSAL ESOPHAGEAL CANCER; SURGICAL INFECTION; THORAX DRAINAGE; TRANSHIATAL ESOPHAGECTOMY; TRANSTHORACIC ESOPHAGECTOMY; UNITED STATES; VOCAL CORD PARALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REOPERATION; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78349233141     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181fcd730     Document Type: Conference Paper

References (29)

1. Pech O, Behrens A, May A, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia andmucosal adenocarcinoma in Barrett's oesophagus. Gut 2008 57(9) 1200-1206.
2. Stein HJ, Feith M, von Rahden BH, et al. Approach to early Barrett's cancer. World J Surg 2003;27(9):1040-1046.
3. Stein HJ, von Rahden BH, Feith M. Surgery for early stage esophageal adeno-carcinoma. J Surg Oncol 2005;92(3):210-217.
4. Westerterp M, Koppert LB, Buskens CJ, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005;446(5):497-504.
5. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg2005;242(4):566-573; discussion 573-575.
6. Hölscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer. Comparison between adeno-and squamous cell carcinoma. Cancer 1995;76(2):178-186.
7. Bollschweiler E, Baldus SE, Schroder W, et al. Highrate oflymph-node metas-tasis in submucosal esophageal squamous-cell carcinomas and adenocarcino-mas. Endoscopy. 2006;38(2):149-156.
8. Stein HJ, Feith M, Mueller J, et al. Limited resection for early adenocarcinoma inBarrett's esophagus. Ann Surg 2000;232(6):733-742.
9. Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy World J Surg 2001;25(4):424-431.
10. Ancona E, Guido E, Cutrone C, et al. A new endoscopic technique for suspen-sion ofesophageal prosthesis for refractory caustic esophageal strictures. Dis Esophagus 2008;21(3):262-265.
11. Stein HJ, Feith M. Surgical strategies for early esophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2005;19(6):927-940.
12. Schröder W, Gutschow CA, Hölscher AH. Limited resection for early esophageal cancer?Langenbecks Arch Surg. 2003;388(2):88-94.
13. Tachibana M, Kinugasa S, Shibakita M, et al. Surgical treatment ofsuperficial esophageal cancer. Langenbecks Arch Surg 2006;391(4):304-321.
14. Hulscher JB, Tijssen JG, Obertop H, et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001;72(1):306-313.
15. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662-1669.
16. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resec-tion compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992-1000; discussion 1000-1001.
17. Lerut T, Coosemans W, Decker G, et al. Surgical techniques. J Surg Oncol. 2005;92(3):218-229.
18. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adapta-tion of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240(6):962-972; discussion 972-974.
19. Hagen JA, Peters JH, DeMeester TR. Superiority ofextended en bloc esoph-agogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg. 1993;106(5):850-8; discussion 858-859.
20. Rizzetto C, DeMeester SR, Hagen JA, et al. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection af-ter neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2008; 135(6):1228-1236.
21. Sobin L. TNM Classification ofMalignant Tumors. 6th ed. New York: Wiley, Hoboken NJ; 2002
22. Japanese Society for Esophageal Diseases. Guidelines For Clinical And Patho-logicalStudies. Carcinoma of the Esophagus. 9th ed. Tokyo: Kanehara; 2001.
23. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240(2):205-213.
24. Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15(11):3278-3288.
25. Peyre CG, Hagen JA, DeMeester SR, et al. The number oflymphnodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549-556.
26. Peyre CG, Hagen JA, DeMeester SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008;248(6):979-985.
27. Buskens CJ, Westerterp M, Lagarde SM, et al. Prediction ofappropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS andhistopathologic features. Gastrointest Endosc. 2004;60(5):703-710.
28. Rampado S, Bocus P, Battaglia G, et al. Endoscopic ultrasound: accu-racy in staging superficial carcinomas of the esophagus. Ann Thorac Surg. 2008;85(1):251-256.
29. Vazquez-Sequeiros E, Wiersema MJ, Clain JE, et al. Impact of lymphnode stag-ing on therapy ofesophageal carcinoma. Gastroenterology. 2003;125(6):1626-1635.